BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 26, 2008
View Archived Issues
AT1-AAs implicated in pre-eclampsia in mouse studies
Read More
Novel treatment options for anemia described in recent GSK patent
Read More
NeoPharm reveals new agents for atopic dermatitis in recent patent
Read More
Subtype-selective GABA-A receptor modulator reduces neuropathic hypersensitivity in vivo
Read More
RGH-478 reduces pain in arthritis models
Read More
Biogen commences phase III Adentri trial in acute decompensated heart failure
Read More
Glycine transporter inhibitors identified at Merck for the treatment of schizophrenia
Read More
Pilot study finds no effect of atorvastatin on CSF HIV-1 infection
Read More
FRANCIS trial commences in patients within acute coronary syndrome
Read More
Indevus completes patient enrollment in phase III PRO-2000 trial
Read More
MMRC and Celgene collaborate on phase I/II pomalidomide trial
Read More
Alpharma rejects takeover proposal from King Pharmaceuticals
Read More
BioAlliance is granted main patent in Europe for Lauriad
Read More
Recent Mitsubishi Tanabe patent discloses new anxiolytic compounds
Read More
rhNRG-1 improves donor heart preservation in animal studies
Read More
Biovail gains Canadian approval for Ralivia for moderately severe pain
Read More
Generex signs oral insulin distribution deal with Dong-Sung for Korea
Read More
Invitrogen plans meeting for proposed merger with Applied Biosystems
Read More
Oxygen Biotherapeutics to meet with FDA for proposed phase IIb Oxycyte trial
Read More
QLT enters into exclusive license agreement with Reckitt for Atrigel technology
Read More
NeuroDiscovery reports results from phase IIa clinical trials of NSL-101 in dental surgery
Read More
Resverlogix initiates phase Ib/IIa program for RVX-208
Read More
Recent Janssen patent imparts new therapeutic agents for gastrointestinal disorders
Read More
